Clinical Trials

A clinical trial, published in the medical journal ‘GUT’, focused on diagnosed sufferers of Irritable Bowel Syndrome.  The IgG test study was designed by the University Hospital of South Manchester and used on 150 out patients who had been diagnosed as suffering from IBS - using the YORKTEST Laboratories foodSCAN IgG ELISA test (enzyme-linked immunosorbent assay). The study looked at the effectiveness of an exclusion diet based on the results of the YORKTEST IBS test.

 

Patients were randomly selected to receive a diet based on their blood test results eliminating the foods they were intolerant to, or a dummy diet, eliminating food to which they were not sensitive.  The trial followed patients for three months and the severity of symptoms recorded. It showed that the elimination diet based on the true results was “significantly more effective” than the dummy diet in reducing the severity of IBS symptoms.